Market Tracker

04/29 9:58am ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.43
BATS BZX Real-Time Price
As of 9:57am ET
 -0.07 / -1.27%
Today’s Change
3.61
Today|||52-Week Range
11.15
-11.42%
Year-to-Date

Today’s Trading

Previous close5.50
Today’s open5.49
Day’s range5.43 - 5.53
Volume5,259
Average volume (3 months)995,360
Market cap$384.7M
Dividend yield--
Data as of 9:57am ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-1,033.33%
Earnings growth (this year)+137.50%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-80.45%
P/E ratioNM
Price/Sales49.26
Price/Book4.22

Competitors

 Today’s
change
Today’s
% change
SGNTSagent Pharmaceutica...-0.34-2.83%
ADMSAdamas Pharmaceutica...+0.16+0.96%
VNDAVanda Pharmaceutical...+0.05+0.49%
SVASinovac Biotech Ltd+0.04+0.55%
Data as of 9:57am ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$8.7M
Annual profit (last year)-$39.1M
Net profit margin-450.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Head-
Operations
Meryl J. Longval
Corporate headquarters
Tarrytown, New York

Forecasts